Boston Scientific Says Stock Buys DQ Hopeful Lead Plaintiff

By Julie Manganis · July 27, 2023, 7:29 PM EDT

Boston Scientific Corp. asked a Massachusetts federal judge Thursday to disqualify a German asset-management firm from serving as lead plaintiff in a proposed shareholder class action, arguing that the firm continued...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

In re Boston Scientific Corporation Securities Litigation

Case Number

Court

Massachusetts

Nature of Suit

Stockholders Suits

Date Filed

December 16, 2020

Recent Articles By Julie

November 13, 2024
JPMorgan, Health System In Talks To Settle Email Scheme Suit
November 07, 2024
DOL Secretary Seeks Unpaid OT From Health Staffing Cos.
November 06, 2024
Mass. Voters Reject Tipped Minimum Wage Proposal
October 17, 2024
Ex-Genzyme Exec Says Anxiety Disclosure Led To Firing
October 15, 2024
Motley Rice May Avoid DQ In Boston Opioid Case, Judge Hints
October 10, 2024
Teva To Pay $450M To Settle Kickback Cases
October 08, 2024
Mass. Seeks Order Forcing Steward To Maintain Coverage
September 24, 2024
Moderna Execs Hyped Ineffective RSV Vax, Suit Says
September 23, 2024
Mass. General Asks Court To End Fat Removal Patent License
September 18, 2024
Mass. Appeals Court Backs Pot Shop's Arbitration Agreement